Intel has now added 27% in a single week and 38% over the past month, closing Tuesday at $123.86 — yet the shorts who covered furiously last week have started quietly rebuilding, and the Street remains deeply split with five weeks to go before Q3 earnings on October 22.
The more important data point this week is not the price but what's happening underneath it. Short interest has risen 3.3% over the past week to 3.3% of free float — a modest but deliberate rebuild after the sharp unwind documented in last week's note. The month-on-month picture is starker: SI is up 34% over 30 days, driven by the mid-September accumulation before the squeeze, then partially unwound, and now gently climbing again. Borrow conditions offer no friction to new shorts. Availability is essentially unlimited — the lending pool carries over five billion shares available, a reading that has been pinned at its ceiling for weeks. Cost to borrow is 0.34%, down 14% on the week and a fraction of the double-digit rates that prevailed through August's peak short buildup. There is no squeeze pressure here. Options positioning reinforces the picture: the put/call ratio at 0.86 is slightly below its 20-day average of 0.88 — call-skewed by about 1.3 standard deviations — consistent with a market that has been buying into the rally rather than hedging against it. Taken together, the positioning landscape is unusual: shorts rebuilding into a stock where borrowing is nearly free, availability is vast, and options traders are still leaning bullish.
The Street reflects the same tension. The consensus mean target of $116 now sits below the $123.86 close — a reversal from last week when that target implied 20% upside from $97. Tigress Financial raised its target to $145 just last week. Northland upgraded to Outperform at $120. Against that, Mizuho holds a $92 target and Piper Sandler initiated at Neutral with $110, both now materially below the market price. The bull case — yield improvements on 14A, the Terafab AI partnership, and a potential external foundry customer — has been enough to push the stock past the optimistic targets in a matter of days. The bear case points to a P/E of roughly 65x and a price-to-book of 5.3x, both of which have expanded sharply with the rally: P/B is up 1.5x over 30 days alone. EPS momentum at the 90-day level ranks in the 89th percentile, which supports the bulls on fundamentals, but the earnings yield has compressed to just 1.5% — a signal that the market is now paying steeply for the recovery story.
The insider register adds one clear data point worth noting. CEO Lip-Bu Tan made an open-market purchase of $10 million worth of shares on August 11 at $95 — a discretionary buy, not under a 10b5-1 plan, and the most significant insider transaction in recent months. At $123.86, that trade is already up 30%. It remains one of the cleaner signals of executive conviction in the turnaround, though it predates the most recent leg of the rally. On the institutional side, FMR added 34.7 million shares in the period ending August 31 — the largest directional move among the major holders — while BlackRock and Capital Research also added meaningfully.
Earnings history is worth keeping in mind. The last two prints each produced a move of approximately 10% lower the following day, with the five-day move settling around minus 11%. The Q3 report on October 22 arrives with the stock now 30% above where those prior reactions started. That history does not determine what happens next — but it frames the risk asymmetry that the rebuilding shorts and the newly cautious analysts are pricing around.
What to watch: whether short interest continues to climb back toward its pre-squeeze levels in the weeks before October 22, and whether any bellwether firm moves its target above the current price to give the rally fresh fundamental cover.
See the live data behind this article on ORTEX.
Open INTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.